Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report)’s stock price traded down 1.6% during trading on Tuesday . The company traded as low as $27.04 and last traded at $27.11. 31,960 shares were traded during mid-day trading, a decline of 21% from the average session volume of 40,498 shares. The stock had previously closed at $27.55.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Otsuka from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Otsuka presently has a consensus rating of “Hold”.
Get Our Latest Research Report on OTSKY
Otsuka Stock Down 1.6%
Otsuka Company Profile
Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Further Reading
- Five stocks we like better than Otsuka
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Where Do I Find 52-Week Highs and Lows?
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
